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Abstract
Background. In  this  paper  we  propose  a  method  and  discuss  its  computational
implementation as an integrated tool for the analysis of viral genetic diversity on data
generated  by  high-throughput  sequencing.  The  main  motivation  for  this  work  is  to
better  understand  the  genetic  diversity  of  viruses  with  high  rates  of  nucleotide
substitution,  as  HIV-1  and  Influenza.  Most  methods  for  viral  diversity  estimation
proposed so far are intended to take benefit of the longer reads produced by some NGS
platforms in order to estimate a population of haplotypes which represent the diversity
of the original population. Our goal here is to take advantage of distinct virtues of a
certain NGS platform – the platform SOLiDTM (Life Technologies) – that has not received
much attention due to the short length of its reads, which renders haplotype estimation
very difficult. However, the platform SOLiDTM has a very low error rate and extremely
deep  coverage  per  site  and  our  method  is  designed  to  take  advantage  of  these
characteristics.
Results. We propose to measure the populational genetic diversity through a family of
multinomial probability distributions indexed by the sites of the virus genome, each one
representing  the  populational  distribution  of  the  diversity  per  site.  Moreover,  the
implementation of  the method focuses on two main optimization strategies:  a  read
mapping/alignment  procedure  that  aims  at  the  recovery  of  the  maximum  possible
number  of  short-reads;  the  estimation  of  the  multinomial  parameters  through  a
Bayesian  approach  based  on  Dirichlet  distributions  inspired  by  word  count  in  text
modeling. The Bayesian approach, unlike simple frequency counting, allows one to take
into account the prior information of the control population within the inference of a
posterior experimental condition and provides a natural way to separate signal  from
noise, since it automatically furnishes Bayesian confidence intervals. 
Conclusions. The  methods  described  in  this  paper  have  been  implemented  as  an
integrated tool called  Tanden (Tool for Analysis of Diversity in Viral  Populations) and
tested on samples obtained from HIV-1 strain NL4-3 (group M, subtype B) cultivations
on primary human cell cultures in many distinct viral propagation conditions. Tanden is
written  in  C#  (Microsoft),  runs  on  the  Windows  operating  system,  and  can  be
downloaded from: http://tanden.url.ph/
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Background
Viral  biology  is  surprisingly  diversified,  and  viruses  with  RNA  genomes  are
recognized to generate particularly mutant-rich populations called  quasi-species.  The
genetic  heterogeneity  characteristic  of  viral  quasi-species  is  largely  due  to  high
mutational  rates  combined  with  an  elevated  populational  size  [1]. Human
Immunodeficiency virus 1 (HIV-1), as an example, has a mean substitution rate of order
10-5 per nucleotide position [2]; that is by far higher than those of cellular organisms [3,
4] and assures a constant viral mutant production.
Next-Generation Sequencing (NGS) platforms have been used mainly for the de
novo sequencing  of  viruses.  However,  more  recently,  new  interest  arose  in  re-
sequencing known virus genomes using NGS to study the diversity of viral populations.
All  NGS platforms produce short segments of DNA, called  reads,  which provide only
imperfect  and  incomplete  information  about  the  structure  of  the  viral  population.
Sequencing errors and length of reads are factors that must be taken into account in the
analysis of data obtained from NGS viral quasi-species. In addition, reverse transcription
and PCR amplification are procedures prone to errors. The impact of these errors on
studies of viral diversity could be huge (see below), therefore one wants to separate
true genetic variation from methodological noise and if both are of the same order of
magnitude the task  becomes virtually impossible. 
Regarding  the  development  of  tools  to  estimate  genetic  diversity  of  viral
populations,  the  most  commonly  used  NGS  platforms  are  the  454TM  (Life
Sciences/Roche), mainly due to their capacity to produce long reads but now in disuse,
and the IlluminaTM (Solexa). The ability to produce relatively long sequences favors the
development of methods aiming at the haplotype reconstruction of the representative
particles in population [5, 6]. However, the propagation of sequencing errors is a serious
problem  in  these  methods,  requiring  the  development  of  procedures  for  error
correction, which my introduce unwanted biases. In general, the fraction of wrong reads
increases with the error rate and the average length. The expected proportion of reads
with at least one sequencing error as a function of the error rate per base  ε and the
average length L of reads is given by 1-(1-ε)L [7]. As the estimated error rate of 454TM is
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about 0.1% - 0.5% and IlluminaTM error rates are in the range of 0.1% - 1% [8], with an
average length of reads from 400 bp up to 1000 bp, the proportion of reads with at least
one  error  is  in  the  range  35%  -  90%.  The  platform  SOLiDTM (Life  Technologies),  for
instance, is at the other end of the spectrum. With reads of short length, of at most 50
bases (the main limitation for the construction of haplotypes) and estimated error rate
of 0.06% [8], the proportion of reads with at least one error is around 2%. Recently, a
different solution to the problem of sequencing errors has been proposed [9], based on
the development of high-fidelity sequencing protocols [10].
A  more  serious  challenge  concerns  the  NP-hardness of  combinatorial
optimization problem associated with the assembly of all possible haplotypes  [11]. In
fact, some approximate solution must be employed and a crucial hindering factor is the
rate  between  the  size  of  the  reads  and  the  size  of  the  genomic  region  being
reconstructed. For instance, it has been reported [9] that short read lengths (less than
100 base  pairs)  dramatically  inhibit  reconstruction of  genomes of  length  3400 base
pairs, evidenced by the failing to produce any complete genome.
As  mentioned  before,  the  ability  of  the  other  NGS  platforms  to  produce
relatively long sequences have been a great stimulus to the development of methods
for  building  haplotype  representatives of  the  particles  in  population  and  the  vast
majority of softwares for viral diversity estimation that have been proposed until very
recently  adopt  this  perspective  [5]. The  aim  of  this  work  is  to  propose  a  different
approach to genetic diversity evaluation that takes advantage of the low error rate and
the high depth of coverage per site inherent to the SOLiDTM platform and therefore we
shall  considerably  depart  from the  developments  towards  haplotype  recosntruction.
Indeed,  although  the  short  length  of  the  reads  produced  by  the  SOLiDTM platform
essentially hinders haplotype reconstruction, it is possible to measure the populational
genetic diversity through probability distributions along the genome (one per site) and
this  approach  is  enhanced  by  the  highly  deep  coverage  provided  by  the  SOLiDTM
platform. 
A  recent  study  [12] comparatively  assessed  the  performance  of  some  NGS
platforms (including 454TM and IlluminaTM) and reported an average (range) coverage of
~23000 reads (5000-47000) for the IlluminaTM and ~7000 reads (2000-22000) for the
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454TM. We were able to achieve an average (range) coverage of ~50000 reads (10000-
150000), for instance, see Figure 1. In addition, the low error rate of 0.06 % provided by
the  SOLiDTM platform  virtually  eliminates  the  necessity  of  any  error  correction
procedure. Instead, we use the estimated probability distributions to separate signal
from noise.
The first step in nucleotide sequence analysis is read mapping/alignment. This is
important  for  many  bioinformatics  applications,  as  exemplified  by  nucleic  acid
conformational structure prediction and phylogeny studies [13, 14]. As expected, this is
also an important aspect for Next Generation Sequencing (NGS) data analysis involving
all  the  different  platforms  as  Ion  TorrentTM (Life  Technologies),  SOLiDTM,  454TM and
IlluminaTM [15, 16] and others. Nowadays users can choose from a panoply of tools for
mapping and indexing NGS reads, available on-line and for download. MAQ (Mapping
and Assembly with Qualities) [17], BWA (Burrows-Wheeler Alignment Tool) [18], BFAST
(Blat-like Fast Accurate Search Tool) [19], Bowtie [20] and MOSAIK [21] are examples of
such alternatives. Those tools allow the fast mapping and alignment of reads belonging
to genomes ranging from 106 to 109 bp in length. A common point between these tools
is the use of scaffolding reference sequences [18, 22, 23].
After the read mapping is finished, the following step consists in the choice of a
strategy for statistical inference. There is a wide variety of methods depending on the
scope  and  the  goals  of  the  analysis:  (i)  consensus  generation,  (ii)  single  nucleotide
variant (SNV),  also  called  single  position  diversity  estimation,  (iii)  local  diversity
estimation and (iv) read graph-based haplotype reconstruction, also known as  global
diversity estimation, see [7, 24] for a thoroughly explanation of these concepts. Existing
tools for genetic diversity evaluation of viral NGS sequences, intended for 454TM and
IlluminaTM platforms  [7, 24–31], are based on several techniques aiming at haplotype
reconstruction [28, 32–37].
In order to estimate the populational diversity without resorting to haplotype
reconstruction,  we propose to measure the populational  genetic diversity  through a
family of multinomial probability distributions indexed by the sites of the virus genome,
each one representing the populational distribution of the diversity per site. Moreover,
the estimation of the multinomial  parameters is made through a Bayesian  approach
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based on Dirichlet distributions inspired by word count in text modeling. The choice of a
Bayesian estimation is crucial for our method, because it allows one to take into account
the  prior  information  of  the  control  population  within  the  inference  of  a  posterior
experimental  condition by means of Bayes theorem and thus relates two temporally
connected events. It also provides a natural way to separate signal from noise, since it
automatically furnishes credible (or Bayesian confidence) intervals. On the other hand,
simple frequency counting, as one could suggest, is neither appropriate nor sufficient
for the implementation of the method. First, because it is not possible to include prior
knowledge into the estimation (for example, we know in advance the genome of the
control) and second, it does not provide a natural way to obtain confidence values for
the estimate. 
In  summary,  we sought  to build an analysis  platform suitable to address the
problem  of  estimation  of  the  populational  diversity  of  RNA  viruses.  Due  to  high
mutational  rates  and  accelerated  populational  turnover  RNA  viruses  constitute
ensembles of variants. These ensembles known as quasi-species behave as a single and
coherent organism and host pressures are thought to act on the ensemble of variants
rather than on individual particles  [38]. Based on the above assumptions and the fact
that the SOLiDTM platform generates an extremely high number of reads allowing for a
deep and extensive coverage of the data with very low error rate, we propose a simple
approach – based on very few elementary assumptions – to the estimation of genetic
diversity of viral populations.
Unfortunately, we could not find any other method or software in the literature,
which  uses  a  similar  form to  represent  the viral  population diversity  as  a  family  of
distributions  index  by  the  genome –  all  other  proposals  are  aimed  at  haplotype
reconstruction and need longer reads  (more than 100 bases).  Any attempt to make
comparison between such different aproaches would be misleading, therefore it is not
our aim here to make the point if the method presented here is an improvement over
(non-)existing similar ones. In fact, we believe that the approach proposed here should
not be considered alternative or rival, but complementary, to haplotype reconstruction.
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The technical analysis and conclusions about the experiments reported in this
paper  and used as  test  cases,  are  not  necessary to the description of  the methods
introduced here and will be the subject of another publication [39]. 
Implementation
Here we describe the main steps of our method. There are two stages,  the first
is the read mapping/alignment and the second is the nucleotide inference. The method
presented here works, in principle, for data generated in any NGS machine, as long as
the data is stored in the FASTA file format, even several outputs from different platforms
(with distinct read lengths) may be combined and analyzed simultaneously.
1. Experimental procedure and preparation
The computational  tool  developed here  assumes that  there is  one,  or   even
several, experimental condition(s), representing different viral propagation situations, all
of which, having the same viral population as the infecting source. After a determined
number of replicative cycles an extracted sample from each experimental condition may
be sequenced. A sample from the initial population prior to the infections must also be
sequenced  and  will  be  referred  as  the  control  experiment.  Raw  data  from  the
sequencing must be treated according to the standard procedures of the specific NGS
platform [40] up to the generation of FASTA files, which are the standard type of input
file adopted in our implementation. See Table 1 for a summary of data analyzed.
2. Read Mapping/Alignment 
The main goal of this step is the mapping of reads with 50 nucleotides or more
originating from the NGS platform to a database of reference sequences. The database
may contain several sequences, which must be aligned amongst themselves  The read
mapping is performed using a local executable of BLAST [41] with the default options.
The  criteria  for  retaining  the  reads  are  the  following:  (i)  it  must  align  at  least  45
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nucleotides and (ii) have the lowest  e-value score. A first alignment attempt is made
with sequences from reads in the forward sense; in case of no match, a second attempt
with the reverse complementary sequence is performed. Moreover, since we are using
several references, the output can, in principle, display the same number of matches as
there  is  reference  sequences.  The  criteria  for  the  selection  of  the  most  suitable
alignment option are the following (in this order): (i) the lowest e-value score and (ii) the
lowest  Hamming distance from the consensus sequence obtained from of the control.
The alignment strategy described above is set as default, but some of its parameters can
be changed according to some specific purposes or  simply  for  increasing processing
speed. Finally, it is possible to create suitable reference databases according to a specific
research purposes.
3. Nucleotide Estimation
The  probability  distributions  of  the  possible  nucleotides  (A,T,C,G)  at  each
position  of  the  genome  are  estimated  from  the  aligned  data.  In  this  respect,  our
approach may be classified as a diversity estimation in single positions. The idea is that
at each position in the genome the probability distribution is given by a  multinomial
distribution, determined by four probabilities (pA,  pT,  pC,  pG) satisfying  pA+pT+pC+pG=1.
These probabilities represent the fraction of the population that has each of the four
associated nucleotides at the corresponding site. Thus, one has a family of multinomial
distributions indexed by the sites of the genome. In this sense one can view the nucleic
acid sequences of a population as a collection of text documents and the task is to
estimate the frequency of each character in each document.
The  Bayesian  approach provides  an  adequate  framework  [42,  43] for the
inference of categorical data without the shortcomings of a simple frequency counting
procedure. In this framework, the first step consists in using the experimental control as
the input for estimation of a initial distribution. Then, in the second step, one considers
this distribution as the  prior distribution together with the sequenced data form the
experimental conditions one uses Bayes formula to compute the posterior distribution.
In the case of categorical data there is a canonical procedure based on the conjugate
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prior  distribution associated  with  the  multinomial  distribution,  called  Dirichlet
distribution.
A  n-dimensional  Dirichlet  distribution is  defined  in  by  a  smooth  probability
density  function  on  the  set  Δ  of  n-dimensional  multinomial  distributions,  which  is
parametrized as  Δn =  {(p1,…,pn−1)  :  p1+…+pn−1 ≤ 1},  here  n is  the number of  distinct
categories (states)  that  can observed and  pk is  the probability of  observing the  k-th
category, for k = 1,…,n with pn = 1−p1+…+pn−1 . The Dirichlet probability density function
is given by
Dir(p1,…,pn−1|α1,…,αn) = 1/B(α) ∏
k
 pkαk−1 ,
where B(α) is a normalizing factor defined in terms of the gamma function Γ as
B(α) = ∏
k
 Γ(αk) / Γ(∑
k
 αk).
for a vector  α =(α1,…,αn).  Note that the choice  (α1,…,αn) = (1,…,1) gives the uniform
distribution (the flat or uninformative prior) on Δn with mass equal to the volume of Δn :
B(1,…,1) = 1/Γ(n) = 1/(n−1)!.  Thus a member in the family of Dirichlet distributions is
characterized by a n-tuple of positive numbers α =(α1,…,αn)  called hyper-parameters –
however,  unlike  the  multinomial  parameters  that  must  sum  to  one,  the  hyper-
parameters  are  unconstrained.  In  our  case,  the Dirichlet  distribution of  each  site  is
parametrized by the quadruple (αA, αT,  αC, αG). The hyper-parameters corresponding to
each site of the genome must be estimated from the data.
The  Dirichlet  hyper-parameters  associated  to  the  control  experiment  can  be
obtained  by  maximum  likelihood  estimation  (MLE)  through  the  Newton-Raphson
method. The log-likelihood function g of the Dirichlet distribution is given by g = N log L
and
log L(α1,…,αn |p1,…,pn) = log Γ(∑
k
 αk) − ∑
k
 log Γ(αk) + ∑
k
 (αk−1) log pk  ,
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where N is the sample size and log pk = 1/N ∑ j log pjk (j=1,…,N,  k=1,…,n) is called the
sufficient statistics associated to a sample of n-categorical vector observations {p1,…,pN}
of sample size N. Thus each vector pj=(pj1,…,pjn) has n components, each component pjk
is the frequency of the k-th category at the j-th sample.
The  Newton-Raphson method for this log-likelihood function g amounts to the
iteration of the following fixed-point scheme [42]:
αnew = αold + [H−1 ∇g](αold),
where  αnew and αold are vectors  of  Dirichlet hyper-parameters, ∇g(α) is  the  gradient
vector of the log-likelihood function g, with components
[∇g(α)]k = Ψ(∑
k
 αk) − Ψ(αk) + log pk ,
where Ψ = (log Γ)'  is  the  digamma function.  The matrix H−1(α) is  the inverse of the
hessian  matrix of  the  log-likelihood  function  g and  the  product  (H−1  ∇g)(α) has
components [(H−1 ∇g)(α)]k given by
[(H−1 ∇g)(α)]k = (Ψ'(αk))-1 ((∇g)k + (∑
l
 (∇g)l / Ψ'(αl )) / (1/Ψ'(∑
l
 αl) − ∑
l
 1/Ψ'(αl))),
where Ψ' is the trigamma function (k,l=1,…,n). Several suggestions for the initialization
step of the iteration scheme described above have appeared in the literature [43–45].
The proposal  of Ronning  [45] is the most suitable for the modified iteration scheme
adopted here.
Since we are dealing with a sparse estimation problem in the sense that one of
the categories occur with much higher frequency that the other three, we shall employ
the smoothed sufficient statistics defined by introducing a small parameter η and setting
pjk =  Mjk  / M, where  Mjk is the number of occurrences of the  k-th category at the  j-th
sample, M is total number of observations at the j-th sample and pjk =  η if there is no
occurrence of the k-th category at the j-th sample. The smoothing parameter η acts as
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“background noise” representing sequencing and PCR errors that can not be removed.
However it can be suitably tuned in order to account for the true variability of the data.
When this procedure is applied to the control (a “clonal” population) one would expect
no diversity at all. However, that is not completely true and, in fact, even the control
should display some variability (mainly due to sequencing errors). Since the expected
error rate ε is around 6×10-4 a value of the order of 10-5 is a reasonable choice for η. In
the smoothed version of the Newton-Raphson iteration scheme, Ronning's initialization
step is given by setting αold = (η,…,η).
The sufficient statistics is computed by a simple re-sampling procedure [46, 47]
in order to generate sequences of categorical  observations from the raw sequenced
data, by randomly sampling nucleotides form each aligned position. Here, the imperfect
clonality of the control is useful, since it ensure that the re-sampled ensemble has some
variability, which is consistent with having a small non-zero smoothing parameter. The
re-sampling procedure has one parameter that can be adjusted by the user: the relative
size of  observations given as a fraction 0 <  z < 1 of the whole set of  nucleotides  C
covering the given site. If the number of bases covering the given site is C then M=zC is
the number of observations used to compute one sample vector pj=(pj1,…,pjn) and the
corresponding sample size N is given by (the integer part of) the logarithm of the total
number of all possible sample vectors:
N = [ log Γ(C) − log Γ(zC) − log Γ((1− z)C) ] .
Stirling's formula gives the following approximation in terms of C:
N ≈ C (− z log z − (1−z) log (1−z))/log 2 .
For instance, for the default value of z, which is 80%, one has a sample of size N ≈ 0.7C,
each sample vector computed from 0.8M nucleotides. On the other hand, the value z =
50% gives a sample of size N ≈ C, each sample vector  computed from 0.5M nucleotides
Once the hyper-parameters of the prior distribution are estimated, they must be
used together with the sequenced data of the other experimental conditions in order to
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compute the hyper-parameters of the posterior distributions by Bayes formula, which in
the case of Dirichlet distributions can be computed explicitly (since it  is a conjugate
prior): if (α1,…,αn) is a vector of hyper-parameters of a Dirichlet prior distribution and
the counts of each of the k categories in an experiment are (c1,…,cn) then the posterior
distribution is also a Dirichlet distribution with hyper-parameters (α1+c1,…,αn+cn).  As a
result, one obtains a family of Dirichlet probability distributions for every experimental
condition, including the control experiment.
In order to obtain point estimates of categorical probabilities per site for each
experimental condition (pA,  pT,  pC,  pG), one may use a central tendency measure of the
corresponding Dirichlet distribution (see  [42]). Let  X = (X1,…,Xn) be a random vector
distributed according to a Dirichlet distribution with corresponding hyper-parameters
(α1,…,αn) then the number  s  =  α1+…+αn is called the  concentration parameter of the
corresponding  Dirichlet  distribution.  It  provides  a  measure  of  the  “quality”  of  the
inference: the greater the value of s  the better is the “precision” of the inference (see
[42]). The expectation value of X is
E(Xk) = αk / s .
Confidence  values  associated  to  the  point  estimates  may  be  defined  in  terms  of  a
dispersion measure  of  the corresponding  Dirichlet  distribution.  The  variance of  X is
given by
Var(Xk) = αk (s − αk) / (s2 (s + 1)) .
Since the marginal  distribution of each  Xk is a one-dimensional Dirichlet distribution,
also known as Beta distribution, the standard deviation of the mean σ(X)=√Var(X) may
be used to construct Bayesian credible intervals about the expectation value.
The maximum a posteriori (MAP) estimate, which is given by the mode of X, has
become a very popular method of point estimation [9]. Moreover, the coordinates xk of
the mode of X may be directly calculated in terms of the hyper-parameters when αk > 1
(k = 1,…,n):
xk =  αk / (s − n) .
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This  is  much simpler than the contrived expectation-maximization (EM) approximate
schemes usually employed to obtain the MAP estimate from a log-likelihood function, in
which case approximations are unavoidable, since this function is non-convex.
The  the  standard deviation of the mean σ(Xk) may be used to define credible
intervals about the mode as well. Since the Beta distribution is unimodal, when all αk > 1
(k = 1,…,n), and has finite variance, a 3-sigma interval around the mean or the mode
would provide about 95% of confidence in the prediction (this is a general consequence
of the Gauss-Vysochanskij-Petunin inequality, see  [48]).
Finally, we should note that the inference procedure explained above is clearly
not restricted to the case of four nucleotides (A,T,C,G). It is trivial to modify it in order to
account for insertions and deletions, or to work with codons and amino-acids.
4. Selection Criteria and Error Filtering
Once the inference has been completed it is desirable to filter the errors and
extract some subset of the data – for instance, most conserved sites, most variable sites,
etc.  In order to do so we have implemented two selection criteria based on simple
quantities: (i) complementary probability per site and (ii) variational distance per site. 
The complementary probability per site is defined as pcomp = 1−max{pA, pT, pC, pG}
and it depends only on the probability distribution of each site. It provides a measure of
how  much  the  distribution  is  concentrated  in  one  state.  For  instance,  if  the
complementary probability at a site is high it means that there was variation in the site
prior to the experiment.
The variational distance per site is a positive number between 0 and 2 defined
by  vd  = |pA−p'A|+|pT−p'T|+|pC−p'C|+|pG−p'G|,  where (pA,  pT,  pC,  pG)  is  the probability
distribution  per  site  in  the  control  data  and  (p'A,  p'T,  p'C,  p'G)  is  the  probability
distribution of the corresponding site in the experimental condition. It is a measure of
the relative variation per site from the control to the experimental procedure data. If it
is very low at a site it means that the site did not undergo significant changes in relation
to the control.
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The complementary probabilities and the variational distance can work as filters
and  the  user  must  specify  the  thresholds  for  them.  By  using  these  two  criteria  in
combination one may easily obtain some qualitative information about the behavior at
a site.
Results and Discussion
The method presented here was tested on samples obtained after the HIV-1
strain NL4-3 (group M, subtype B) cultivation on primary human cell cultures. Different
viral propagation conditions were used – varying the cellular activation status, the co-
receptor  usage  and  the  target  cells.  The  pseudo-typed  viruses  produced  in  these
experiments were able to perform exactly one round of the replicative cycle. As a whole,
there were 7 experimental conditions in addition to the control experiment (Table 1).
1. Experimental procedure and preparation 
The experimental  procedure was performed in accordance with the standard
procedures of the NGS platform SOLiDTM [40], up to the generation of FASTA files, which
are the input data of our computational tool. Standard Life Technologies guidelines were
used during sample preparation and sequencing while using the SOLiDTM platform v. 3.0.
The size of the FASTA files containing the reads of each condition is around 700Mb,
consisting of about 107 reads.  
2. Read Mapping/Alignment
The  use  of  BLAST  to  perform  the  read  mapping  has  two  reasons:  first  the
multiple reference sequences allowed by BLAST makes it advantageous for analysis of
viral  populations  classically  described as  quasi-species,  since we can  include  several
variant genomes belonging to the same phylogenetic branch. Second, is the speed and
the readiness of parallelization, since, for each experimental condition, we need to align
about 107 reads with 50 base pairs against 103 reference sequences, each with 104 sites,
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in  the  case  of  HIV.  We  used  a  reference  database  composed  by  1258  sequences,
properly aligned, of representatives of HIV-1 epidemics, most of them belonging to M
group and its subtypes A, B, C, D, F, G, H, J, K, and recombinants. Some of the sequences
are  of  complete  HIV-1  genomes  while  others  represented  virtually  (more  than  90%
complete)  complete  genomes.  All  sequences  are  available  at  NCBI/Genbank.  The
reference database also contains sequences from HIV-1 group O, SIVcpz and HIV-1 strain
NL4-3 and is packaged together with the software. 
Even though BLAST is capable of identifying alignments in both the forward and
the reverse complementary senses, we have found that manually doing this significantly
increases the retrieval of reads. Indeed, we have achieved an increase of 15% in the
retrieval of reads. Since the procedure have been parallelized into multiple threads it
has a minor effect on the performance when using a multi-core processor.
We were able to map around 90% of the reads, since the estimated fraction of
reads with at least one error is around 2%, we have achieved an almost optimal retrieval
of  reads.  For  instance,  Figure  1  shows  the  result  of  the  alignment  of  the  control
experiment and the corresponding site coverage. The average site coverage is around
50000 reads with some peaks going beyond 150000 reads.  The running-time on each
experimental condition was around 30 hours on a Intel i7 (12 cores, clock of 3.30 GHz)
with 32 GB of RAM memory and 2 TB of disk space. It is worthwhile mentioning that the
program uses at most 3 cores and requires 2.8 GB of RAM memory to handle files with
700 MB, thus it is conceivable that the program could run on any computer matching
this minimal configuration.
3. Inference
An  important  difficulty  that  should  be  overcome  in  order  to  implement  the
inference procedure for Dirichlet hyper-parameters in the context of nucleotides is due
to the  sparsity.  Even with the high mutation rate displayed by viruses, there is a fair
amount  of  nucleotide  conservation.  From  a  populational  point  of  view,  most  of
individuals will present the same nucleotide at a specific genomic position, and only the
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less  representative  subgroups,  if  any,  will  present  one  of  the  three  remaining
possibilities. 
The standard Bayesian method outlined in most textbooks, where one usually
chooses an uninformative (uniform) prior distribution is appropriate for the general task
of  multinomial  estimation  [49],  but  generally  provides  poor  results  when  used  for
sparse  multinomial  distributions.  This  is  primarily  a  consequence  of  the  erroneous
assumption that all categories should be considered as equally possible values for each
site. Indeed, sparse multinomial distributions are characterized by the fact that only a
few symbols actually occur  (site  conservation).  In  such cases,  applying the standard
method will give too much weight to symbols that never occur and consequently give a
poor estimate of the true distribution. This  issue becomes critical  in our case when
treating data  obtained from the  control  experiment,  which,  in  principle,  is  a  clonal
population, where one expects a uniquely well-defined nucleotide at each site and thus
the Dirichlet likelihood function would be identically zero.
The  sparsity  problem  is  usually  solved  in  the  literature  of  text  modeling  by
introducing a  smoothing parameter η and modifying the Newton-Raphson method in
such a way that the sufficient statistics does not have any zero entry.  In practice, this
may result in an over-smoothed distribution, but one can choose a small enough value
for  η in  such  a  way  that  all  the  rare  events  do  not  have  the  same  probability  of
appearing in all states [50].
4. Validation
The method described here contains some heuristic decisions that should be
justified  and  properly  validated.  We  have  performed  validation  procedures  at  both
stages of the method (alignment and inference), attaining very good concordance with
the expected results.
In order to assess the reliability of the read mapping procedure and validate this
stage,  the  quality  values (QV) of the reads have been used as a proxy.  The SOLiDTM
platform outputs two files after primary analysis [43, 44]: a sequence file in color-space
and a quality file containing the corresponding quality values. The QV of a read is a
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positive  integer  ranging  from 0  to  50  and is  given  by  the  logarithm of  the  inverse
probability  of  the color  call  being  inaccurate,  i.e. the  higher  the QV the higher  the
confidence in the color call's accuracy. By computing the distribution of quality values of
the reads in each experimental condition and the control, prior and after the alignment,
and comparing them, it is observed that they are almost identical (see Figure 2). This
shows that the alignment procedure does not introduces any bias towards higher or
lower quality values. The reliability of the read mapping procedure is guaranteed by the
stringency of the criteria for retaining the reads.
The  validation  of  the  read  mapping  procedure  was  done  by  computing  the
distributions of all quality values of each condition prior and after the alignment (see
Figure 2). The mean value of the QV distributions remained unchanged after alignment.
Likewise,  at  both  steps  of  the  process  more  than 80% of  reads  had QV comprised
between 20 and 32, assuring that the quality of the retrieved sequences was preserved
and no bias was introduced.
The validation of the nucleotide inference step is performed at two points. The
re-sampling procedure has been validated by comparing, at each site, the nucleotide
frequencies  obtained  from  all  the  reads  that  cover  the  site  with  the  nucleotide
frequencies obtained from the sampled reads that cover the site. It is observed that
both frequencies agree with high precision (up to order 10-4).  This  ensures that the
sufficient statistics obtained is the correct one. The validation of the implementation of
the  Newton-Raphson scheme for  the  Dirichlet  maximum likelihood is  performed by
computing the MLE for a standard data-set, which is not sparse. The data set for pollen
counts  analyzed  in  Mosiman  is  often used for  testing  Dirichlet  maximum likelihood
implementations (see [42]). Since our implementation has a smoothing parameter, it is
expected that the obtained values converge to the known values when the parameter
approaches  zero.  It  is  indeed  observed  that  this  convergence  occurs,  with  perfect
agreement occurring above the order of magnitude of the smoothing parameter.
We  have  included  in  the  software  the  appropriate  options  for  the  user  to
perform these validation procedures. In particular, it is possible to run the Dirichlet MLE
on any data set (with 4 categories, in the present version) given   as a list of multinomial
observations.
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5. Error filtering
The concentration parameter s of the control is a measure of the quality of the
inference: when s > 1 the inference may be considered meaningful. Sites with s ≤ 1 may
be  excluded from further  analysis.  Sites  with  low value  of  s may  happen due poor
coverage and total conservation (all reads with the same nucleotide at that position).
The  complementary  probability  of  an  ideal  clonal  population would  be
identically  zero.  However,  in  the  smoothed  inferential  scheme  proposed  here  it  is
expected that  pcomp  ≈  η.   Furthermore, due to sequencing and PCR errors (and other
events which may have occurred prior to cloning the initial genome), pcomp may, in fact,
display  a  broad  distribution  over  the  genome  (see  Figure  3).  In  any  case,  the
complementary probability of the control may be considered as an average error rate
per site and its distribution over the genome may be used to set a cut off value for
separating the signal from the noise (everything below this value should be considered
noise). It is expected that MODE(pcomp) ≈ η, that is, the majority of sites will behave as in
a  clonal  population  and  this  indeed  is  the  case  (see  Table  2).  However,  due  to
sequencing errors it expected to have a concentration of  pcomp near the error rate  ε =
6×10-4. Since the distribution of pcomp is extremely skewed with a long tail, the median is
a  better  measure  of  centrality  than  the  mean  value.  In  fact,  we  have  found  that
MEDIAN(pcomp) ≈ ε as expected (see Table 2). 
The  expectation  MEAN(pcomp),  which  is  very  sensitive  to  the  long  tail,  is  a
reasonable choice of a cut off value for noise filtering, a more conservative choice would
be MEAN(pcomp)+SD-MEAN(pcomp). The cut off value for pcomp can be used to obtain a cut
off value for the variational distance as CUT-OFF(vd) =2×CUT-OFF(pcomp),  since  vd is a
piece-wise linear function of the probabilities.
After the nucleotide probability distributions of the control was computed we
have found 40 genomic positions with concentration parameter s less or equal than 1.
These genomic positions correspond to portions of the genome where the coverage
dropped substantially in comparison with the mean coverage (~102 reads). These sites
were excluded from the remaining analysis.  The expectation is  MEAN(pcomp)  =  0.002
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(that is,  probabilities are considered significantly distinct if  they differ by more than
0.02%).  The  conservative  choice  of  cut  off  value  is  given  by  MEAN+SD-MEAN  =
0.002+0.018 = 0.02 (see Table 2). The complementary probability may also be used to
make sure that the variability observed in the experimental conditions is not a feature
that  has  been  transferred  from  the  control  to  the  experimental  condition.  The
distribution of  the  complementary  probabilities  of  the  control  shows  that  98.5% of
genomic positions have  pcomp < 0.02 (this means less than 2% of nucleotide variation).
The  remaining  1.5%  genomic  positions  correspond  to  sites  were  the  population
acquired its variation prior to exposition to the experimental condition (see Figure 5).
The  posterior  probability  distributions  of  all  7  experimental  conditions  were
computed. Figure 5 presents the values of the variational distance between the control
and one of the experimental conditions and its distribution is shown in Figure 5, lower
panel.  Considering  the  same  conservative  cut  off  value  of  0.04  for  the  variational
distance (Figure 5, upper panel), one has that 98% of the genomic positions felt under
this threshold, these are sites that did not display nucleotide variation after exposition
to the experimental  condition. The remaining 2% genomic positions contains all  the
populational variation acquired after exactly one round of the replicative cycle. Further
analysis of these results and their implications for the study of HIV will be subject of
another publication [39].
Conclusions
High  throughput  sequencing  technologies  are  constantly  evolving  and  new
platforms and refinements in the chemistry and base calling algorithms are constantly
improving. Recently the PacBioTM sequencer has been gaining space as it produces long
reads,  but with a large number of randomly generated sequencing errors  [51]. New
approaches to sequencing using known technologies have been proposed, such as circle
sequencing  for  Illumina  [52]. We  expect  that  the  proposed  approach,  with  slight
modifications can be adopted for other technologies such as Ion TorrentTM, IlluminaTM
(HiSeq, MiSeq and NextSeq) and PacBioTM .
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We have described a platform suitable to address the problem of estimation of
populational diversity of RNA viruses.  Based on the fact that the SOLiDTM sequencing
platforms  generate  an  extremely  high  number  of  reads  allowing  for  a  deep  and
extensive coverage of the data with very low error rate, we propose to measure the
populational genetic diversity through a family of probability distributions indexed by
the sites of  the genome, each one representing the populational distribution of  the
diversity. This approach allowed us to avoid some hard problems related to haplotype
reconstruction and emphasize the main features of the sequencing technology used in
this work, the SOLiDTM platform. 
We have tested the method proposed here on samples obtained after the HIV-1
strain NL4-3 (group M, subtype B) cultivation on primary human cell cultures in many
distinct viral propagation conditions, thus successfully demonstrating the capability of
the method in handling large data-sets and delivering very clean results, suggesting that
the software is a valuable tool for investigating the genetic diversity in viral populations.
We have successfully demonstrated Tanden's capability of handling large data-sets and
delivering  very  clean  results,  suggesting  that  the  software  is  a  valuable  tool  for
investigating  the  genetic  diversity  in  viral  populations  as  a  complementary  to  some
haplotype reconstruction method.
Availability and requirements
Project name: Tanden
Project web site: http://tanden.url.ph/
Operating systems: Windows
Programming language: Microsoft - C#
License: free to all users under the LGPL license
Minimum requirements: 4GB RAM (16GB recommended), 500 GB disk space
Competing interests 
The authors declare that they have no competing interests.
20
Authors' contributions 
JPZ: contributed to the statistical analysis, developed and implemented the software,
drafted the  manuscript; SNB:  carried  out  the  biological  analysis,  contributed  to  the
statistical analysis, drafted the manuscript; ACV: contributed to NGS and bioinformatics
analysis,  drafted  the  manuscript;  GCO:  contributed  to  NGS  bioinformatics  analysis,
drafted the manuscript; LMRJ: conceived the statistical analysis, contributed to NGS and
biological  analysis,  drafted  the  manuscript;  FA:  conceived  the  statistical  analysis,
developed and implemented the software, contributed to  NGS and biological analysis,
drafted the  manuscript.  All  authors  read  and  approved the  final  manuscript  before
submission.
Acknowledgements 
The ideas presented in this paper were developed in collaboration with Francisco A. R.
Bosco, who suddenly passed away in December of 2012.
Funding 
FAR Bosco received support from FAPESP (Brazil) through the grant 08/04531-2 (2009-
2011). SNB received support from CAPES (Brazil) and FAPESP (Brazil). JPZ is supported by
CAPES (Brazil). ACV and GCO thank the Program for Technological Development in Tools
for Health PDTIS FIOCRUZ (RPT01F-NGS) for use of its facilities. LMRJ received support
from  the  FAPESP  project  “In  vitro  study  of  the  mutation  rate  of  human
immunodeficiency virus type 1 (HIV-1) in a single replication round”, grant 2009/14543-
0. FA is supported by CNPq (Brazil) through the grant PQ-306362/2012-0.
References
1. Duffy S, Shackelton LA, Holmes EC: Rates of evolutionary change in viruses: patterns 
and determinants. Nat Rev Genet 2008, 9:267–276.
2. Mansky LM, Temin HM: Lower in vivo mutation rate of human immunodeficiency 
virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J 
Virol 1995, 69:5087–5094.
3. Fu Q, Mittnik A, Johnson PLF, Bos K, Lari M, Bollongino R, Sun C, Giemsch L, Schmitz R,
Burger J, Ronchitelli AM, Martini F, Cremonesi RG, Svoboda J, Bauer P, Caramelli D, 
21
Castellano S, Reich D, Pääbo S, Krause J: A Revised Timescale for Human Evolution 
Based on Ancient Mitochondrial Genomes. Curr Biol 2013, 23:553–559.
4. Okoro CK, Kingsley RA, Connor TR, Harris SR, Parry CM, Al-Mashhadani N, Kariuki S, 
Musefula CL, Gordon MA, de Pinna E, Wain J, Heyderman RS, Obaro S, Alonso PL, 
Mandomando I, MacLennon CA, Tapia MD, Levine MM, Tennant SM, Parkhill J, Dougan 
G: Intracontinental spread of human invasive Salmonella Typhimurium pathovariants 
in sub-Saharan Africa. Nat Genet 2012, 44:1215–1221.
5. Beerenwinkel N, Zagordi O: Ultra-deep sequencing for the analysis of viral 
populations. Curr Opin Virol 2011, 1:413–418.
6. Schopman NCT, Willemsen M, Liu YP, Bradley T, Kampen A van, Baas F, Berkhout B, 
Haasnoot J: Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. 
Nucleic Acids Res 2012, 40:414–427.
7. Beerenwinkel N, Günthard HF, Roth V, Metzner KJ: Challenges and opportunities in 
estimating viral genetic diversity from next-generation sequencing data. Front 
Microbiol 2012, 3:16.
8. Mardis E: Next-Generation Sequencing Technologies. In Current Topics in Genome 
Analysis. National Human Genome Research Institute: 
http://www.genome.gov/12514288; 2014:1–26.
9. Mangul S, Wu NC, Mancuso N, Zelikovsky A, Sun R, Eskin E: Accurate viral population 
assembly from ultra-deep sequencing data. Bioinforma Oxf Engl 2014, 30:i329–337.
10. Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B: Detection and 
quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci
U S A 2011, 108:9530–9535.
11. Huang A, Kantor R, DeLong A, Schreier L, Istrail S: QColors: an algorithm for 
conservative viral quasispecies reconstruction from short and non-contiguous next 
generation sequencing reads. In Silico Biol 2011, 11:193–201.
12. Giallonardo FD, Töpfer A, Rey M, Prabhakaran S, Duport Y, Leemann C, Schmutz S, 
Campbell NK, Joos B, Lecca MR, Patrignani A, Däumer M, Beisel C, Rusert P, Trkola A, 
Günthard HF, Roth V, Beerenwinkel N, Metzner KJ: Full-length haplotype reconstruction
to infer the structure of heterogeneous virus populations. Nucleic Acids Res 
2014:gku537.
13. Kumar S, Tamura K, Nei M: MEGA3: integrated software for molecular evolutionary 
genetics analysis and sequence alignment. Brief Bioinform 2004, 5:150–163.
14. Wallace IM, O’Sullivan O, Higgins DG: Evaluation of iterative alignment algorithms 
for multiple alignment. Bioinformatics 2005, 21:1408–1414.
22
15. Shendure J, JI H: Next-generation DNA sequencing. Nat Biotechnol 2008, 26:1135–
1145.
16. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, 
Durbin R, Subgroup 1000 Genome Project Data Processing: The sequence 
alignment/map format and SAMtools. Bioinformatics 2009, 25:2078–2079.
17. Li H, Ruan J, Durbin R: Mapping short DNA sequencing reads and calling variants 
using mapping quality scores. Genome Res 2008, 18:1851–1858.
18. Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler 
transform. Bioinformatics 2009, 25:1754–1760.
19. Homer N, Merriman B, Nelson SF: BFAST: An alignment tool for large scale genome 
resequencing. PloS ONE 2009, 11:e7767.
20. Langmead B, Salzberg SL: Fast gapped-read alignment with Bowtie 2. Nat Methods 
2012, 9:357–359.
21. Wan-Ping Lee MPS: MOSAIK: A Hash-Based Algorithm for Accurate Next-
Generation Sequencing Short-Read Mapping. PloS One 2014, 9:e90581.
22. Bao S, Jiang R, Kwan W, Wang B, Ma X, Song YQ: Evaluation of next-generation 
sequencing software in mapping and assembly. J Hum Genet 2011, 56:406–414.
23. Flicek P, Birney E: Sense from sequence reads: methods for alignment and 
assembly. Nat Methods 2009, 6:6–12.
24. Goya R, Sun MG, Morin RD, Leung G, Ha G, Wiegand KC, Senz J, Crisan A, Marra MA, 
Hirst M, Huntsman D, Murphy KP, Aparicio S, Shah SP: SNVMix: predicting single 
nucleotide variants from next-generation sequencing of tumors. Bioinformatics 2010, 
26:730–736.
25. Prosperi MCF, Prosperi L, Bruselles A, Abbate I, Rozera G, Vincenti D, Solmone MC, 
Capobianchi MR, Ulivi G: Combinatorial analysis and algorithms for quasispecies 
reconstruction using next-generation sequencing. BMC Bioinformatics 2011, 12:5.
26. Willerth SM, Pedro HAM, Pachter L, Humeau LM, Arkin AP, Schaffer DV: 
Development of a low bias method for characterizing viral populations using next 
generation sequencing technology. PLOS One 2010, 5:e13564.
27. Zagordi O, Däumer M, Beisel C, Beerenwinkel N: Read length versus Depth of 
Coverage for Viral Quasispecies Reconstruction. PLOS One 2012, 7:e47046.
28. Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW: Characterization of 
mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug 
resistance. Genome Res 2007, 17:1195–1201.
23
29. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, Han CS, Gleasner 
CD, Green L, Lo CC, Nag A, Wallstrom TC, Wang S, McMichael AJ, Haynes BF, Hahn BH, 
Perelson AS, Borrow P, Shaw GM, Bhattacharya T, Korber BT: Transmission of single HIV-
1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. 
PLOS One 2010, 5:e12303.
30. Lataillade M, Chiarella J, Yang R, Schnittman S, Writz V, Uy J, Seekins D, Krystal M, 
Mancini M, McGrath D, Simen B, Egholm M, Kozal M: Prevalence and clinical 
significance of HIV drug resistance mutations by ultra-deep sequencing in 
antiretroviral-naive subjects in the CASTLE study. PLOS One 2010, 5:e10952.
31. Tsibris AMN, Korber B, Arnaout R, Russ C, Lo C-C, Leitner T, Gaschen B, Theiler J, 
Paredes R, Su Z, Hughes MD, Gulick RM, Greaves W, Coakley E, Flexner C, Nusbaum C, 
Kuritzkes DR: Quantitative deep sequencing reveals dynamic HIV-1 escape and large 
population shifts during CCR5 antagonist therapy in vivo. PLOS One 2009, 4:e5683.
32. Bruselles A, Rozera G, Bartolini B, Prosperi M, Del Nonno F, Narciso P, Capobianchi 
MR, Abbate I: Use of massive parallel pyrosequencing for near full-length 
characterization of a unique HIV Type 1 BF recombinant associated with a fatal 
primary infection. AIDS Res Hum Retroviruses 2009, 25:937–942.
33. Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, 
Ricklefs SM, Selig EJ, Porcella SF, Munshaw S, Ray SC, Piwowar-Manning E, McCauley M, 
Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Bruyn G de, Grinsztejn B, 
Kumarasamy N, Makhema J, Mayer KH, Pilotto J, Santos BR, Quinn TC, Cohen MS, 
Hughes  and JP: Analysis of genetic linkage of HIV from couples enrolled in the HIV 
Prevention Trials Network 052 trial. J Infect Dis 2011, 204:1918–1926.
34. Macalalad AR, Zody MC, Charlebois P, Lennon NJ, Newman RM, Malboeuf CM, Ryan 
EM, Boutwell CL, Power KA, Brackney DE, Pesko KN, Levin JZ, Ebel GD, Allen TM, Birren 
BW, Henn MR: Highly sensitive and specific detection of rare variants in mixed viral 
populations from massively parallel sequence data. PLOS Comput Biol 2012, 
8:e1002417.
35. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, 
Ding L, Wilson RK: VarScan 2: somatic mutation and copy number alteration discovery 
in cancer by exome sequencing. Genome Res 2012, 22:568–576.
36. Eriksson N, Pachter L, Mitsuya Y, Rhee S-Y, Wang C, Gharizadeh B, Ronaghi M, Shafer 
RW, Beerenwinkel N: Viral population estimation using pyrosequencing. PLOS Comput 
Biol 2008, 4:e1000074.
37. Westbrooks K, Astrovskayaa I, Campob D, Khudyakovb Y, Bermanc P, Zelikovsky A: 
HCV quasispecies assembly using network flows. In Bioinformatics Research and 
Applications. Berlin-Heidelberg: Springer-Verlag; 2008:159–170.
38. Domingo E, Sheldon J, Perales C: Viral quasispecies evolution. Microbiol Mol Biol 
Rev 2012, 76:159–216.
24
39. Nascimento-Brito S, Zukurov JP, Maricato JT, Volpini A, Oliveira G, Antoneli F, Janini 
LMR: HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA. 2014.
40. Biosystems A: Applied Biosystems SOLiD(TM) 3 System: Instrument Operation Guide. 
2009.
41. Altschul SF, Gish W, Miller W, Myers EW, Lipmanl DJ: Basic local alignment search 
tool. J Mol Biol 1990, 215:403–410.
42. Ng KW, Tian G-L, Tang M-L: Dirichlet and Related Distributions: Theory Methods and 
Applications. Volume 889. Wiley; 2011.
43. Wicker N, Muller J, Kalathura RK, Pocha O: A maximum likelihood approximation 
method for Dirichlet’s parameter estimation. Comput Stat Data Anal 2008, 52:1315–
1322.
44. Narayanan A: A note on parameter estimation in the multivariate beta distribution.
Comput Math Appl 1992, 24:11–17.
45. Ronning G: Maximum likelihood estimation of dirichlet distributions. J Stat Comput
Simul 1989, 32:215–221.
46. Efron B, Gong G: A Leisurely Look at the Bootstrap, the Jackknife, and Cross-
Validation. Am Stat 1983, 37:36–48.
47. Efron B: The Jackknife, the Bootstrap, and Other Resampling Plans. Philadelphia, Pa: 
Society for Industrial and Applied Mathematics; 1987.
48. Pukelsheim F: The Three Sigma Rule. Am Stat 1994, 48:88.
49. O’Hagan A, Forster JJ: Bayesian Inference. 2nd edition. Volume 2B. London: Arnold; 
2004. [Kendall’s Advanced Theory of Statistics]
50. Madsen R, Kauchak D, Elkan C: Modeling Word Burstiness Using the Dirichlet 
Distribution. In Proceedings of the 22nd International Conference on Machine Learning. 
Bonn, Germany; 2005:545–552.
51. Roberts RJ, Carneiro MO, Schatz MC: The advantages of SMRT sequencing. Genome
Biol 2013, 14:405.
52. Lou DI, Hussmann JA, McBee RM, Acevedo A, Andino R, Press WH, Sawyer SL: High-
throughput DNA sequencing errors are reduced by orders of magnitude using circle 
sequencing. Proc Natl Acad Sci 2013, 110:19872–19877.
25
Tables
EXPERIMENTAL CONDITION READS NUCL. MAPPED TIME(HOUR)
HIV1 - Non-stimulated CD4/R5 1.11x107 5.53x108 91.81 % 34.88
HIV2 - Stimulated CD4/R5 1.04x107 5.19x108 90.84 % 34.18
HIV3 - Non-stimulated CD4/X4 1.10x107 5.50x108 91.22 % 29.05
HIV4 - Stimulated PBMC/X4 9.41x106 4.71x108 91.14 % 13.63
HIV5 - Stimulated PBMC/R5 1.14x107 5.73x108 90.49 % 24.09
HIV6 - Non-stimulated PBMC/X4 1.12x107 5.62x108 91.42 % 27.54
HIV7 - Non-stimulated PBMC/R5 1.19x107 5.94x108 93.27 % 15.34
HIV8 - Control (pNL4-3kfs) 1.01x107 5.05x108 93.10 % 30.14
TOTAL 8.65x107 4.33x109 91.67 % 208.85
Table 1: Summary of data analyzed. The second column (READS) displays the number of reads sequenced
in each condition, the third column (NUCL.) displays the number of nucleotides in each condition, the
fourth column (MAPPED) displays the percentage of reads that have been mapped and the fifth column
(TIME) displays the time elapsed in each mapping procedure.
STATISTICS pcomp s
Mean 0.00260 3.43
Deviation 0.01824 0.50
Median 0.00066 3.60
Mode 0.00001 3.74
Minimum 0.00001 1.01
Maximum 0.49242 6.26
Table 2: Summary statistics of the complementary probability (pcomp) and the concentration parameter (s)
of the control, after removal of the genomic positions with concentration below 1.
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Figures
Figure 1. Depth and coverage of one SOLiDTM sequencing of the HIV-1 genome.  The major peaks in the
middle representing the most deeply covered regions coincide with the overlapping primers from the PCR
step, an evidence that there is in fact some influence of pre-sequencing phases on the frequency of the
short-reads retained in the alignment. The major peak in the beginning is related to the difficulties in
mapping the LTR region. Other significant peaks maybe due to PCR artifacts, as well.
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Figure  2. Quality  values  (QV)  of  the  short-reads  before  (Blue)  and  after  (Red)  the  alignment.   The
histogram contains the quality values on the horizontal axis  and the proportion of short-reads in the
vertical axis, displaying a  large concentration of values  around the average  (approximately 23) and the
majority (more than 90%) of short-reads in the range 16-32. Short-reads with  quality values in this range
are considered to have excellent fidelity.
Figure  3. Histogram  of  the  complementary  probabilities  of  the  control  data.  The  complementary
probability per site is defined as  pcomp = 1 – max{pA,  pT,  pC,  pG} and it depends only on the probability
distribution of each site. The horizontal axis shows the values of complementary probabilities and the
vertical axis the proportions of sites. The histogram contains the sites with pcomp < 0.02, which comprises
98.5% of all genome. These are the sites that have a unique dominant nucleotide with probability greater
or equal than 0.98. The remaining 1.5% sites are the ones displaying some variability in the distribution of
nucleotides.
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Figure 4. Variational distance (vd) between the control data and an experimental condition along the
genome. The variational distance per site is defined by vd = |pA-p'A| + |pT-p'T| + |pC-p'C| + |pG-p'G|, where
(pA,  pT,  pC,  pG)  is  the probability  distribution per  site  in  the control  data and (p'A,  p'T,  p'C,  p'G)  is  the
probability distribution of the corresponding site in the experimental condition. The horizontal axis shows
the sites of the genome (with the LTR regions removed) and the vertical axis shows  the corresponding
variational distances. Applying the conservative cut-off value of 0.04 for  vd one obtains the sites with
significant variation.
29
Figure 5. Histograms of the relative frequencies of the variational distances (vd). The horizontal axis shows
the variational distances and the vertical axis shows the proportions of sites. The main panel (Red) shows
the sites with vd < 0.04, which comprises 98% of all sites and the upper panel (Blue) shows the sites with
vd > 0.04, which comprises 2% of all sites.
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